[HTML][HTML] Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons
…, A Mba-Jonas, SW Martin… - … England Journal of …, 2021 - Mass Medical Soc
Background Many pregnant persons in the United States are receiving messenger RNA (mRNA)
coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in …
coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in …
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
CG Grijalva, JP Nuorti, PG Arbogast, SW Martin… - The Lancet, 2007 - thelancet.com
Background Routine infant immunisation with seven-valent pneumococcal conjugate vaccine
(PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined …
(PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined …
On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data
CE Rose, SW Martin, KA Wannemuehler… - Journal of …, 2006 - Taylor & Francis
We compared several modeling strategies for vaccine adverse event count data in which the
data are characterized by excess zeroes and heteroskedasticity. Count data are routinely …
data are characterized by excess zeroes and heteroskedasticity. Count data are routinely …
Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010
…, J Talarico, NE Messonnier, TA Clark, SW Martin - Jama, 2012 - jamanetwork.com
Context In 2010, California experienced its largest pertussis epidemic in more than 60 years;
a substantial burden of disease was noted in the 7- to 10-year-old age group despite high …
a substantial burden of disease was noted in the 7- to 10-year-old age group despite high …
National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States
BACKGROUND. Since introduction of the heptavalent pneumococcal conjugate vaccine in
the United States in 2000, rates of invasive pneumococcal disease have declined. However, …
the United States in 2000, rates of invasive pneumococcal disease have declined. However, …
[HTML][HTML] Use of serogroup B meningococcal vaccines in persons aged≥ 10 years at increased risk for serogroup B meningococcal disease: recommendations of the …
T Folaranmi, L Rubin, SW Martin, M Patel… - … and Mortality Weekly …, 2015 - ncbi.nlm.nih.gov
Methods The ACIP Meningococcal Vaccines Work Group reviewed safety and immunogenicity
data from seven clinical trials of MenB-4C (2–7)(Novartis, unpublished data) and nine …
data from seven clinical trials of MenB-4C (2–7)(Novartis, unpublished data) and nine …
Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
SW Martin, L Pawloski, M Williams… - Clinical Infectious …, 2015 - academic.oup.com
An analysis assessing for associations between pertactin production and both clinical
presentation and vaccine history found a significant association between vaccination and pertactin …
presentation and vaccine history found a significant association between vaccination and pertactin …
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
…, TA Clark, L Misegades, SW Martin… - Clinical infectious …, 2013 - academic.oup.com
Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA),
MenAfriVac, was first introduced in mass vaccination campaigns of 1–29-year-olds in Burkina …
MenAfriVac, was first introduced in mass vaccination campaigns of 1–29-year-olds in Burkina …
Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015
…, IR Ortega-Sanchez, M Patel, SW Martin - Morbidity and Mortality …, 2015 - JSTOR
Methods The ACIP Meningococcal Vaccines Work Group reviewed the immunogenicity and
safety data from seven clinical trials of MenB-FHbp (2–5)(Pfizer, unpublished data) and five …
safety data from seven clinical trials of MenB-FHbp (2–5)(Pfizer, unpublished data) and five …
Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine
KA Poehling, PG Szilagyi, CG Grijalva, SW Martin… - …, 2007 - publications.aap.org
OBJECTIVE. Streptococcus pneumoniae is an important cause of otitis media in children. In
this study we estimated the effect of routine childhood immunization with heptavalent …
this study we estimated the effect of routine childhood immunization with heptavalent …